An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation. (2018)
Attributed to:
ERA-NET NEURON: Investigation of the neuroinflammatory basis of the human type I
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1212/wnl.0000000000004921
PubMed Identifier: 29321238
Publication URI: http://europepmc.org/abstract/MED/29321238
Type: Journal Article/Review
Volume: 90
Parent Publication: Neurology
Issue: 6
ISSN: 0028-3878